Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
$1.44
-4.6%
$1.55
$1.18
▼
$3.19
$97.52M0.85582,849 shs435,559 shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$14.82
-1.8%
$17.32
$7.07
▼
$20.15
$1.92B1.871.70 million shs1.18 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
0.00%-16.52%+1.05%-30.10%-48.11%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.00%-7.49%-9.58%-12.72%+44.16%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
$1.44
-4.6%
$1.55
$1.18
▼
$3.19
$97.52M0.85582,849 shs435,559 shs
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$14.82
-1.8%
$17.32
$7.07
▼
$20.15
$1.92B1.871.70 million shs1.18 million shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
0.00%-16.52%+1.05%-30.10%-48.11%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.00%-7.49%-9.58%-12.72%+44.16%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
1.67
Reduce$2.0038.89% Upside
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2.58
Moderate Buy$20.8840.86% Upside

Current Analyst Ratings Breakdown

Latest NCCL, NEO, ARMS, and BHR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/12/2026
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
DowngradeSell (D) ➝ Sell (D-)
10/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Boost Price TargetBuy$19.00 ➝ $23.00
10/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated RatingBuy$21.00
10/29/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated RatingBuy$28.00
10/28/2026
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
Reiterated RatingSell (D)
10/12/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated RatingSell (D-)
10/12/2026
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
Lower Price TargetNeutral$2.50 ➝ $2.00
10/7/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Reiterated RatingOverweight
10/6/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
Boost Price TargetBuy$19.00 ➝ $22.00
9/28/2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
DowngradeStrong-Buy ➝ Hold
(Data available from 11/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
$704.02M0.14$1.21 per share1.19($1.54) per share-0.94
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$787.75M2.43$0.34 per share44.23$6.19 per share2.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
-$22.32M$2.680.54N/AN/A34.68%269.26%13.61%N/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
-$108.03M-$0.25N/A494.00N/A-4.10%-0.99%-0.59%N/A

Latest NCCL, NEO, ARMS, and BHR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026Q3 2026
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
-$0.71-$3.51-$2.80-$3.51$103.61 million$101.58 million
10/28/2026Q3 2026
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$0.0555$0.07+$0.0145-$0.06$206.70 million$209.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
N/AN/AN/AN/AN/A
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
5.03
1.56
1.56
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
0.47
3.53
3.31

Institutional Ownership

CompanyInstitutional Ownership
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
64.79%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
98.50%

Insider Ownership

CompanyInsider Ownership
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
8.20%
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
BRAEMAR HOTELS & RESORTS INC. stock logo
BHR
BRAEMAR HOTELS & RESORTS
11668.68 million63.05 millionOptionable
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
2,500129.39 million127.97 millionOptionable

Recent News About These Companies

NeoGenomics, Inc. (NEO) Q3 2026 Earnings Call Transcript
NeoGenomics (NEO) Q3 2026 Earnings Call Transcript
What NeoGenomics (NEO) Said on Its Q3 Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
BRAEMAR HOTELS & RESORTS stock logo

BRAEMAR HOTELS & RESORTS NYSE:BHR

$1.44 -0.07 (-4.64%)
Closing price 11/20/2026 03:59 PM Eastern
Extended Trading
$1.44 0.00 (-0.35%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Braemar Hotels & Resorts is a conservatively capitalized REIT that invests primarily in high RevPAR, full-service luxury hotels and resorts. We are listed on the New York Stock Exchange under the symbol BHR and are externally-advised by Ashford (NYSE American: AINC).

NeoGenomics stock logo

NeoGenomics NASDAQ:NEO

$14.82 -0.27 (-1.79%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$14.77 -0.05 (-0.32%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.